The increase in price target from $1.75 to $2 by Roth MKM suggests a positive outlook on Cresco Labs' valuation, potentially leading to a short-term positive impact on the stock price. However, the maintenance of a Neutral rating indicates that the analyst sees limited upside or potential challenges that could cap significant gains.